IRIS Accounts Production v24.3.2.46 06333170 director 1.10.23 30.9.24 30.9.24 false false false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063331702023-09-30063331702024-09-30063331702023-10-012024-09-30063331702022-09-30063331702022-10-012023-09-30063331702023-09-3006333170ns15:EnglandWales2023-10-012024-09-3006333170ns14:PoundSterling2023-10-012024-09-3006333170ns10:Director12023-10-012024-09-3006333170ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3006333170ns10:SmallEntities2023-10-012024-09-3006333170ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3006333170ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3006333170ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3006333170ns10:FullAccounts2023-10-012024-09-300633317012023-10-012024-09-3006333170ns10:RegisteredOffice2023-10-012024-09-3006333170ns5:CurrentFinancialInstruments2024-09-3006333170ns5:CurrentFinancialInstruments2023-09-3006333170ns5:Non-currentFinancialInstruments2024-09-3006333170ns5:Non-currentFinancialInstruments2023-09-3006333170ns5:ShareCapital2024-09-3006333170ns5:ShareCapital2023-09-3006333170ns5:RetainedEarningsAccumulatedLosses2024-09-3006333170ns5:RetainedEarningsAccumulatedLosses2023-09-3006333170ns5:NetGoodwill2023-10-012024-09-3006333170ns5:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3006333170ns5:ComputerSoftware2023-10-012024-09-3006333170ns5:FurnitureFittings2023-10-012024-09-3006333170ns5:MotorVehicles2023-10-012024-09-3006333170ns5:NetGoodwill2023-09-3006333170ns5:IntangibleAssetsOtherThanGoodwill2023-09-3006333170ns5:NetGoodwill2024-09-3006333170ns5:IntangibleAssetsOtherThanGoodwill2024-09-3006333170ns5:NetGoodwill2023-09-3006333170ns5:IntangibleAssetsOtherThanGoodwill2023-09-3006333170ns5:FurnitureFittings2023-09-3006333170ns5:MotorVehicles2023-09-3006333170ns5:FurnitureFittings2024-09-3006333170ns5:MotorVehicles2024-09-3006333170ns5:FurnitureFittings2023-09-3006333170ns5:MotorVehicles2023-09-3006333170ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3006333170ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3006333170ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-09-3006333170ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-09-3006333170ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-09-3006333170ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-09-30
REGISTERED NUMBER: 06333170 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

ABBEYWOOD VETERINARY CLINIC LIMITED

ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Statement of Financial Position 2 to 3

Notes to the Financial Statements 4 to 7


ABBEYWOOD VETERINARY CLINIC LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTOR: Dr John Gunn





REGISTERED OFFICE: 104 Ashton Road
Denton
Manchester
M34 3JE





REGISTERED NUMBER: 06333170 (England and Wales)





ACCOUNTANTS: Baker Tilly Mooney Moore
17 Clarendon Road
Clarendon Dock
Belfast
BT1 3BG

ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 33,621 44,829
Tangible assets 5 622 828
34,243 45,657

CURRENT ASSETS
Stocks 6 7,000 3,500
Debtors 7 13,828 5,151
Cash at bank 36,064 108,191
56,892 116,842
CREDITORS
Amounts falling due within one year 8 29,072 98,413
NET CURRENT ASSETS 27,820 18,429
TOTAL ASSETS LESS CURRENT
LIABILITIES

62,063

64,086

CREDITORS
Amounts falling due after more than one
year

9

(4,908

)

(10,908

)

PROVISIONS FOR LIABILITIES (467 ) (647 )
NET ASSETS 56,688 52,531

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 56,686 52,529
SHAREHOLDERS' FUNDS 56,688 52,531

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

STATEMENT OF FINANCIAL POSITION - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 February 2025 and were signed by:





Dr John Gunn - Director


ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Abbeywood Veterinary Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In preparing these financial statements the directors have made the following judgements:

Determine whether there are indicators of impairment of the company's tangible fixed assets. Factors taken into consideration include the economic viability and expected future financial performance of the assets and the business in general.

Consider the age and condition of stock and the need for any impairment provisions. These considerations are undertaken by directors at regular intervals, especially at the year end date. Factors taken into consideration include the period of ownership of the stock, market demand and historical experience. Stock identified as impaired will be provided against in the relevant period.

Consider the recoverability of trade debtors and work in progress and the need for impairment provisions. These considerations are undertaken regularly by the directors and especially at the year end date. Factors taken into account include historical experience, current market conditions and knowledge of the sector. Amounts identified as irrecoverable will be provided against in the relevant period.


The directors also consider the depreciation rate on an annual basis to ensure this estimate remains reasonable.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill is the difference between the amount paid on the acquisition of a business and the aggregate fair value of its separate net assets. Goodwill is being amortised through the profit and loss account over the directors' estimate of its economic life.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures, fittings & equipment - 25% on reducing balance
Motor vehicles - 25% on reducing balance

ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1 October 2023
and 30 September 2024 203,175 8,806 211,981
AMORTISATION
At 1 October 2023 162,541 4,611 167,152
Charge for year 10,159 1,049 11,208
At 30 September 2024 172,700 5,660 178,360
NET BOOK VALUE
At 30 September 2024 30,475 3,146 33,621
At 30 September 2023 40,634 4,195 44,829

ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


5. TANGIBLE FIXED ASSETS
Fixtures,
fittings Motor
& equipment vehicles Totals
£    £    £   
COST
At 1 October 2023
and 30 September 2024 73,031 2,234 75,265
DEPRECIATION
At 1 October 2023 72,225 2,212 74,437
Charge for year 201 5 206
At 30 September 2024 72,426 2,217 74,643
NET BOOK VALUE
At 30 September 2024 605 17 622
At 30 September 2023 806 22 828

6. STOCKS
30.9.24 30.9.23
£    £   
Stocks 7,000 3,500

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 13,717 5,000
Prepayments 111 151
13,828 5,151

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Bank loans and overdrafts 6,592 6,592
Tax 1,410 748
Social security and other taxes 295 91
VAT 1,161 1,965
Directors' current accounts 13,155 83,696
Accrued expenses 6,459 5,321
29,072 98,413

ABBEYWOOD VETERINARY CLINIC LIMITED (REGISTERED NUMBER: 06333170)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.24 30.9.23
£    £   
Bank loans - 1-2 years 4,908 6,592
Bank loans - 2-5 years - 4,316
4,908 10,908